Point-of-Care Ultrasound Market to record CAGR of 14.3% over 2023-2030; Introduction of New and Advanced Products and Need for Superior Medical Imaging is Set to Create Market Opportunities

The global point-of-care ultrasound market size is estimated to display strong growth by reaching USD 3.00 billion by 2030. Fortune Business Insights™ in its report titled “Point-of-care Ultrasound Market Size, Share & COVID-19 Impact Analysis, By Product (Cart-based and Compact & Hand-held), By End User (Hospitals, Clinics, and Others), and Regional Forecast, 2023-2030” observes that the market size in 2022 stood at USD 1.05 billion and is expected to reach USD 1.18 billion in 2023. The market is expected to witness a strong CAGR of 14.3% during 2023-2030. Point-of-care (POC) ultrasound helps in early bedside evaluation of primary treatment and emergency screening among patients in specialty clinics, ambulatory surgical centers, and primary health centers. The introduction of new and advanced products and the need for superior medical imaging in outpatient care settings is expected to strongly surge the growth of the global market in developed and emerging regions during the forecast period.

FUJIFILM Sonosite, Inc. Announced the Launch Of A New Sonosite PX Ultrasound System In India

In January 2023, FUJIFILM Sonosite, Inc. announced the launch of a new Sonosite PX ultrasound system in India. FUJIFILM Sonosite specializes in developing cutting-edge point-of-care ultrasound In July 2020, the company launched the system in the U.S. The company is set to expand its business and increase its presence in the global market.

These Tests Were Used For Co-Morbid Respiratory Pathologies For Lung Pathology And Pathological Changes

In COVID-19 patients, these tests were used in the diagnosis of co-morbid respiratory pathologies for lung pathology and pathological changes.  Moreover, the use of hand-held devices increased in emergency units of hospitals due to their convenient handling and less sterilization requirement, further stabilizing the market growth in 2021. An increase in the uptake of ultrasound tests among the general population at homecare settings further propelled the market growth at a substantial pace in 2021. In October 2021, as per the article published by the Diagnostic and Interventional Radiology, the point-of-care ultrasound had rapid growth in the increase at homecare settings for health visits and monitoring of patients.

Various Advantages of Ultrasound Devices to Drive Market Growth

Various advantages of ultrasound devices are predicted to drive point-of-care ultrasound market growth. The demand for ultrasound devices is high due to the simultaneous rise in diagnostic tests and screening. The conventional cart-based ultrasound equipment in routine diagnostic imaging offers detailed high-resolution images and has a varied application area across healthcare settings. Compact and hand-held devices are portable, safe, and economical to use, making them suitable for decision-making. Increasing adoption of ultrasound devices in cardiology, and gastroenterology, across developed countries, is set to drive the product demand.

However, use of hand-held devices is the lack of experienced technicians is anticipated to hinder market growth. It will also lead in poor imaging results and incorrect disease assessment.  

To get a detailed report summary and research scope of this market, click here:

https://www.fortunebusinessinsights.com/point-of-care-ultrasound-market-103343

Investments by the Key Market Players to Create a Competitive Edge for the Market

Key manufacturers operating in the market are GE HealthCare, Siemens Healthineers, Koninklijke Philips N.V., FUJIFILM Sonosite, Inc., and TERASON DIVISION TERATECH CORPORATION. Other emerging companies in the market are China-based, including, CHISON Medical Technologies Co., Ltd., and EDAN Instruments. In May 2022, GE HealthCare announced to invest USD 50.0 million in Pulsenmore for the adoption of ultrasound solutions and FDA clearance and commercial expansion.

Key Industry Development

• February 2022: Butterfly Network, Inc., introduced Butterfly Blueprint in the U.S., which includes a set of optional services and software, including Caption Health’s AI-guided software. This software helps healthcare professionals without sonography expertise to capture and interpret cardiac ultrasound images for early detection of disease.

List of Key Companies Profiled in the Market Report:

• GE HealthCare (U.S.)


• Koninklijke Philips N.V. (Netherlands)


• FUJIFILM Sonosite, Inc. (U.S.)


• ALPINION MEDICAL SYSTEMS Co., Ltd. (South Korea)


• Hitachi Ltd. (Japan)


• Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)


• EDAN Instruments (China)


• TERASON DIVISION TERATECH CORPORATION (U.S.)


• CHISON Medical Technologies Co., Ltd. (China)


• Healcerion Co., Ltd. (South Korea)


• Butterfly Network, Inc. (U.S.)


• Becton, Dickinson, and Company (U.S.)


• Zimmer MedizinSysteme GmbH (Germany)


• Teknova Medical Systems Co., Ltd. (China)


• Advanced Instrumentations (Florida)


• DRE Medical (U.S.)


• DRAMIŃSKI S. A. (Poland)


• Shenzhen AnaSonic Bio-Medical Technology Co., Ltd. (China

Further Report Findings

• North America dominated the market share due to the introduction of innovative and compact ultrasound devices. The market stood at USD 0.42 billion in 2022 due to rising awareness and adoption of ultrasound devices by healthcare professionals for point-of-care applications.  


• Europe is set to be the second-largest region in the market due to the rising number of patients undergoing diagnostic screening for cardiovascular and respiratory diseases.


• In Asia Pacific, the market growth with the highest CAGR due to the increasing prevalence of chronic disorders.

Table of Segmentation